Plain-English translation of NCT05283993 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →This is a long-term research study that enrolls patients diagnosed with plasma cell disorders—a group of conditions where certain white blood cells produce too many antibodies and cause problems throughout the body. Researchers will track your health over time, collect blood and bone marrow samples, and monitor how well your treatment is working. The goal is to better understand what factors predict which patients will do better or worse, and how the tumor environment around cancer cells may affect outcomes.
Plasma cell disorders can be very different from person to person, and doctors don't yet fully understand which patients will have the best outcomes with current treatments. This study aims to gather detailed information over many years to help doctors predict outcomes better and develop more personalized treatment plans in the future.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital at baseline (when you start) and then at 1, 3, 6, and 12 months after beginning treatment, with yearly visits after that. At each visit, doctors will collect blood samples, bone marrow samples, and urine samples, and review your medical history and lab results. The study will follow you over several years to see how your condition changes and how you respond to treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China